FDA recommendations to inform psychedelic drug development
Drug Discovery World
JUNE 27, 2023
Sponsors evaluating the therapeutic potential of these drugs should consider their unique characteristics when designing clinical studies,” said Tiffany Farchione, Director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research. “By
Let's personalize your content